MetaOptics proposes dual listing on Nasdaq

SGX Filings
Nov 17, 2025

MetaOptics Ltd announced on Nov, 17 2025 that it intends to pursue a secondary listing on the Nasdaq Stock Market in New York, United States.

The company said the proposed Nasdaq listing is expected to broaden its investor base by attracting U.S. institutional and private investors, provide an additional trading platform for its securities, and enhance its flexibility to raise capital for future fund-raising or strategic initiatives, including potential mergers and acquisitions.

Management added that proximity to the U.S. market would support MetaOptics’ plans to strengthen its metalens design and fabrication capabilities and to engage more closely with prospective customers for next-generation optical technologies.

MetaOptics has appointed, or is in the process of appointing, a lead underwriter, legal adviser and external auditor to facilitate the proposed listing. As of the announcement date, no formal application has been submitted to Nasdaq, the U.S. Securities and Exchange Commission, or the Singapore Exchange.

The company cautioned that the plan is at an early stage and remains subject to due diligence, regulatory and shareholder approvals, market conditions and other factors, and it may choose not to proceed even if approvals are obtained.

MetaOptics said it will release further announcements as material developments occur.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10